Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • PhyliCS: A Python library package to quantify Intra-tumor Heterogeneity

The gene responsible for eye lens formation revealed!

Culture-free rapid bacterial infection diagnosis without laboratory

PhyliCS: A Python library package to quantify Intra-tumor Heterogeneity
  • BiotechToday
  • World

PhyliCS: A Python library package to quantify Intra-tumor Heterogeneity

BioTech Today July 5, 2021July 4, 2021

Sayak Banerjee, Amity University Kolkata

Intra-tumor Heterogeneity ( ITH)

Aggregation of a distinct set of somatic mutations leads to the generation of tumors. The set of mutations assembled by the prime tumor is known as clonal and the mutations which take place in pre-existing tumors comprise cancer cell sub-populations is known as subclonal. Consequently, the cancer cells are depicted as an intrinsic genetic diversity, and this overall phenomenon is termed Intra-tumor Heterogeneity ( ITH).

ITH being highly responsible for tumor relapse and failure in treatments has been a topic of huge interest for the cancer research community. The assessment of ITH has been usually done using deconvolution techniques on bulk DNA sequencing data which are based on models of machine learning. It mainly involves clustering the mutations into subclones based on their occurrence and exploiting these clusters to decipher the tumor phylogenetic structure. It has been observed in many studies that using multiple samples taken from different areas of the same tumor enhances the efficacy to decipher the subclonal structure of tumors and evaluate ITH.

Methods for evaluation of ITH

In their paper, the scientists have mentioned the use of the single-cell DNA sequencing (scDNA-seq) method for achieving such efficacy so that the subclonal somatic mutations are not misinterpreted as clonal. This technique enabled them to analyze ITH with extraordinary resolution. The single-cell whole-genome sequencing is convenient for the detection of chromosomal aberrations which can be exploited to reconstruct the subclonal cell population structure. Methods for single-cell Copy Number Aberrations ( scCNA) analysis are limited although the scCNA profiles from different samples of the same tumor could be exploited to analyze the spatial distribution of subclones inside a tumor mass.

Working of PhyliCS

Hence, they have presented a modular, flexible, and user-friendly package of python libraries called PhyliCS. PhyliCS is a valuable instrument that allows us to discover the extent of spatial heterogeneity in the multiple samples from different regions of the tumor mass. It not only aids in evaluating various tumors based on their heterogeneity but also determines the most differing spatial samples of a given tumor. Moreover, the researchers stated that it might assist in exploring multiple tumors without selecting numerous sequenced cells or specific regional samples. In addition to that, PhyliCS serves as easy access to many clustering techniques for both single and multiple samples to users. This makes it easier to compare results and modify each analysis to each experiment.

The scientists ran it on 300 simulated datasets for confirming the SHscore (Spatial Heterogeneity score) on some selected ideal situations where it compares sets of cells with known relationships. This was followed by a more extensive simulation experiment where they displayed the correlation between the anticipated SHscore and the evolutionary distance between the sample cells in the analysis. Finally, they demonstrated the results of the analysis on three publicly accessible scDNA datasets. One of them consisted of a primary lung tumor and its derived metastasis, another one with multiple spatial samplings from a breast tumor, and the last one with a cell line and two clonal expansions of two single cells. All of them were implemented using the SHscore to illustrate how their CN profiles vary when the researchers considered a fine-grained single-cell level in a bigger context of multiple sampling.

They concluded that in the future, scDNA sequencing must gain recognition and more datasets would be available on a public platform. By then they promised to increase their score on large-scale datasets. Furthermore, they also mentioned that it would be fascinating to exploit different single-cell measurements like scRNA and ATACseq, and this would widen the horizon. The option to build a library will decrease the difficulties of future endeavors in this field.

Reference:

  1. Montemurro, M., Grassi, E., Pizzino, C.G. et al. PhyliCS: a Python library to explore scCNA data and quantify spatial tumor heterogeneity. BMC Bioinformatics 22, 360 (2021). https://doi.org/10.1186/s12859-021-04277-3
  2. The thumbnail image has been extracted from Servier Medical Art.

About author:

Sayak Banerjee is a 3rd-year Biotechnology Engineering Student with a great interest in Immunology and Molecular genetics. He is a creative scientific writer in Bioxone with an inclination towards gaining knowledge regarding various sections of Biotechnology and emphasizing himself in various wet lab skills.

Publications:

  • https://bioxone.in/news/worldnews/car-t-cells-scientists-discover-on-off-switches-for-cell-immunotherapy/
  • https://bioxone.in/news/worldnews/neutrophil-derived-nanovesicles-a-novel-drug-delivery-system/
  • https://bioxone.in/news/worldnews/pig-to-human-heart-transplantation-a-solution-to-the-rarity-of-donor-organs/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged aberration Bioinformatics cancer cells chromosomal aberrations DNA sequencing Machine Learning Mutation phylogenetic python somatic mutation tumor

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Culture-free rapid bacterial infection diagnosis without laboratory

BioTech Today July 5, 2021

Richa Prakash, Central University of Punjab Currently, we rely on the enrichment method for the detection and identification of any bacterial infection. This may include enrichment bacterial culture (increasing the number of the organism of interest to a level it can be detected) or PCR (Polymerase Chain Reaction) to amplify the nucleic acids to increase […]

bacterial infection

Related Post

  • BiotechToday
  • World

EBV-encoded miRNAs regulate type-I IFN response and JAK/STAT signaling pathways

bioxone December 9, 2020December 9, 2020

Souradip Mallick, National Institute of Technology, Rourkela  Epstein-Barr virus(EBV) is a DNA virus that belongs in the γ-herpesvirus family that produces lifelong infection and severe diseases-  Burkitt lymphoma(BL). The virus mainly affects immune-compromised individuals suffering from nasopharyngeal cancer, and post-transplant lymphoproliferative disease (PTLD).  The EBV genome encodes different classes of non-coding RNAs including two long […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Scientists identify Aneuploidy as a biomarker for cancer treatment

bioxone February 19, 2021February 19, 2021

Sayak Banerjee, Amity University Kolkata  Multiple genetic changes direct cancer from mutations to aneuploidy. Aneuploidy is the presence of an unusual number of chromosomes in cancer cells. It is estimated that inherently, 90% of solid tumors, like breast cancer and colon cancer, and 75% of blood cancers are caused by aneuploidy. Although being an indication […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

2dFDR for confounder adjustment

bioxone July 17, 2021July 17, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Genomic profiling technologies of a high-throughput level generate a massive number of omics data. This is because such technologies enable biological system analysis at different omics levels. Statistical analysis of omics data tests the relationship between omics aspects and a covariate of interest. Observational omics studies […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy